BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen PY, Chen CH, Chang CK, Kao CF, Lu ML, Lin SK, Huang MC, Hwang LL, Mondelli V. Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics. Int J Neuropsychopharmacol 2019;22:28-36. [PMID: 30204875 DOI: 10.1093/ijnp/pyy075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Goh KK, Chen CY, Wu T, Chen C, Lu M. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. IJMS 2022;23:7092. [DOI: 10.3390/ijms23137092] [Reference Citation Analysis]
2 Chen CY, Goh KK, Chen CH, Lu ML. The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia. Front Psychiatry 2020;11:605124. [PMID: 33551872 DOI: 10.3389/fpsyt.2020.605124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu Z, Zhang Y, Zhao T, Wang J, Xia L, Zhong Y, Yang Y, Ning X, Zhang Y, Ren Z, Liu H. A higher body mass index in Chinese inpatients with chronic schizophrenia is associated with elevated plasma orexin-A levels and fewer negative symptoms. Nordic Journal of Psychiatry 2020;74:525-32. [DOI: 10.1080/08039488.2020.1755995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chang SC, Goh KK, Lu ML. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World J Psychiatr 2021; 11(10): 696-710 [PMID: 34733637 DOI: 10.5498/wjp.v11.i10.696] [Reference Citation Analysis]
5 Lis M, Stańczykiewicz B, Liśkiewicz P, Misiak B. Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics. Psychoneuroendocrinology 2020;119:104744. [DOI: 10.1016/j.psyneuen.2020.104744] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
6 Lu J, Huang ML, Li JH, Jin KY, Li HM, Mou TT, Fronczek R, Duan JF, Xu WJ, Swaab D, Bao AM. Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain. Schizophr Bull 2021;47:1310-9. [PMID: 33974073 DOI: 10.1093/schbul/sbab042] [Reference Citation Analysis]
7 Li S, Zhang R, Hu S, Lai J. Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis. Front Psychiatry 2022;13:879414. [DOI: 10.3389/fpsyt.2022.879414] [Reference Citation Analysis]
8 Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circ 2020;6:70-80. [PMID: 33033776 DOI: 10.4103/bc.bc_42_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sneller MH, de Boer N, Everaars S, Schuurmans M, Guloksuz S, Cahn W, Luykx JJ. Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review. Front Psychiatry 2021;12:625935. [PMID: 33868046 DOI: 10.3389/fpsyt.2021.625935] [Reference Citation Analysis]
10 Chen P, Chiu C, Hsieh T, Liu Y, Chen C, Huang C, Lu M, Huang M. The Relationship of Antipsychotic Treatment with Reduced Brown Adipose Tissue Activity in Patients with Schizophrenia. Psychoneuroendocrinology 2022. [DOI: 10.1016/j.psyneuen.2022.105775] [Reference Citation Analysis]
11 Chen PY, Chang CK, Chen CH, Fang SC, Mondelli V, Chiu CC, Lu ML, Hwang LL, Huang MC. Orexin-a elevation in antipsychotic-treated compared to drug-free patients with schizophrenia: A medication effect independent of metabolic syndrome. J Formos Med Assoc 2022:S0929-6646(22)00110-3. [PMID: 35396156 DOI: 10.1016/j.jfma.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ren J, Chen Y, Fang X, Wang D, Wang Y, Yu L, Wu Z, Liu R, Zhang C. Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine. Neurosci Lett 2022;:136695. [PMID: 35618081 DOI: 10.1016/j.neulet.2022.136695] [Reference Citation Analysis]